Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSC Life Sciences was a prominent business unit of Computer Sciences Corporation (CSC) that provided specialized technology solutions, consulting, and business process services to the global pharmaceutical, biotechnology, and medical device industries. The company was a market leader in Regulatory Information Management (RIM) and clinical data solutions, notably through its flagship FirstDoc document management platform and the regulatory submission tools acquired from Image Solutions, Inc. (ISI). Following the 2017 merger of CSC with HPE Enterprise Services to form DXC Technology, the division operated as DXC Life Sciences until its software portfolio was divested to Ennov in 2020. During its peak, CSC Life Sciences was instrumental in helping major life science firms navigate complex global regulatory environments and transition to digital eCTD submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSC Life Sciences.